Internal Medicine, Infectious Disease · Cincinnati, OH
NPI
1780110601
Since 2017
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2123 Auburn Ave Ste A44
Cincinnati, OH, 45219
Phone (513) 585-2791
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
371 services
Medicare patients, 2024
82
Average age 74
Drug cost, 2024
$244K
441 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas A Burkhead was code 99232 (hospital e&m - subsequent), 206 times for 60 patients. In total Thomas A Burkhead billed 371 services in 12 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 206 | 60 | $59.66 | $12K |
| 99223 Hospital E&M - Initial | Facility | 60 | 51 | $130.94 | $7,856 |
| 99233 Hospital E&M - Subsequent | Facility | 31 | 15 | $89.71 | $2,781 |
| 99214 Office E&M - Established | Office | 26 | 16 | $91.66 | $2,383 |
| 99213 Office E&M - Established | Office | 24 | 16 | $65.41 | $1,570 |
By year: 2022 $11K for 132 services; 2023 $36K for 461 services; 2024 $29K for 371 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas A Burkhead prescribed most often to Medicare patients was Vancomycin Hcl, with 33 prescriptions and refills. In total Thomas A Burkhead wrote 441 Medicare prescriptions that cost $244K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 33 | 33 | Under 11 | $4,519 |
| Azithromycin Generic | 32 | 42 | Under 11 | $785 |
| Cefadroxil Generic | 31 | 53 | Under 11 | $4,447 |
| Amoxicillin Generic | 30 | 34 | Under 11 | $131 |
| Ceftriaxone Ceftriaxone Sodium | 29 | 29 | Under 11 | $1,049 |
| Levofloxacin Generic | 22 | 24 | Under 11 | $268 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 21 | 21 | Under 11 | $12K |
| Ethambutol Hcl Generic | 18 | 28 | Under 11 | $1,049 |
| Fosfomycin Tromethamine Generic | 17 | 20 | Under 11 | $5,420 |
| Sodium Chloride 0.9 % Sodium Chloride | 17 | 17 | Under 11 | $469 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 16 | 16 | Under 11 | $227 |
| Tigecycline Generic | 14 | 14 | Under 11 | $13K |
| Doxycycline Hyclate Generic | 14 | 14 | Under 11 | $174 |
| Cefepime Hcl Generic | 13 | 13 | Under 11 | $6,100 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 12 | 14 | Under 11 | $48.02 |
Brand drugs: 44 claims; generic drugs: 397 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Thomas A Burkhead were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.